Drugs, prostaglandins, and renal function.
Patrono
C
C
Ciabattoni
G
G
Filabozzi
P
P
Catella
F
F
Forni
L
L
Segni
M
M
Patrignani
P
P
Pugliese
F
F
Simonetti
B M
BM
Pierucci
A
A
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D004232:Diuretics / Q000494:pharmacology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000502:physiology*; D004364:Pharmaceutical Preparations; D011453:Prostaglandins / Q000502:physiology*; D013442:Sulfinpyrazone / Q000494:pharmacology; D013467:Sulindac / Q000494:pharmacology; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D016861:Cyclooxygenase Inhibitors; D004232:Diuretics; D004364:Pharmaceutical Preparations; D011453:Prostaglandins; D013467:Sulindac; D013930:Thromboxane-A Synthase; D001241:Aspirin; D013442:Sulfinpyrazone